rent-now

Rent More, Save More! Use code: ECRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

9780470425138

Zebrafish Methods for Assessing Drug Safety and Toxicity

by McGrath, Patricia
  • ISBN13:

    9780470425138

  • ISBN10:

    047042513X

  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2012-01-24
  • Publisher: Wiley
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $146.08 Save up to $0.15
  • Buy New
    $145.93
    Add to Cart Free Shipping Icon Free Shipping

    PRINT ON DEMAND: 2-4 WEEKS. THIS ITEM CANNOT BE CANCELLED OR RETURNED.

Summary

Zebrafish: Methods for Assessing Drug Safety and Toxicity offers a practical guide for using zebrafish as a tool for toxicology studies. Consolidating key protocols and approaches to help researchers navigate the important and evolving field of zebrafish models for toxicity screening, this new title describes the methods for using the zebrafish as a model organism to assess compound-induced toxicity on all major organs. Individual chapters that concentrate on assays for each organ system are included and various analytical tools including microscopy, microplate readers, high content imaging systems, ECG, blood pressure monitors, high speed video and motion detectors are described.

Author Biography

Patricia McGrath, MBA, is President and CEO of Phylonix Pharmaceuticals, Inc. She has some twenty-five years of experience in high-tech and biotechnology management. Phylonix Pharmaceuticals develops and markets novel in vivo zebrafish-based assays for therapeutic and industrial screening for cancers, central nervous system and cardiovascular diseases, apoptosis, and toxicity.

Table of Contents

Prefacep. xi
Contributorsp. xiii
Acknowledgementsp. xvii
The Reproductive Biology and Spawning of Zebrafish in Laboratory Settingsp. 1
Introductionp. 1
Overview of Zebrafish Reproductive Biology and Behaviorp. 2
Spawning Techniques and Technologyp. 5
Determining Factors for Reproduction in Laboratory Stocks of Zebrafishp. 8
Conclusionsp. 11
Referencesp. 11
Developmental Toxicity Assessment in Zebrafishp. 15
Introductionp. 15
Methodsp. 16
Resultsp. 20
Discussionp. 23
Referencesp. 25
Use of Emerging Models for Developmental Toxicity Testingp. 27
Importance of Assessing Developmental Toxicityp. 27
Current Methods for Assessing Developmental Toxicityp. 27
Use of Emerging Models for Developmental Toxicity Testingp. 28
New Guidelines for Chemical Testing Using Zebrafishp. 29
Referencesp. 43
Assessment of Drug-Induced Cardiotoxicity in Zebrafishp. 45
Introductionp. 45
Zebrafish Heartp. 45
Summary of Cardiotoxicity Study Design and Resultsp. 47
Materials and Methodsp. 47
Resultsp. 50
Conclusionsp. 54
Referencesp. 54
Cardiotoxicity Studies in Zebrafishp. 55
Introductionp. 55
Repolarization Toxicityp. 56
Initial Screening: Bradycardiap. 56
High-Resolution Assays of Repolarizationp. 59
Furture Directionsp. 61
Referencesp. 62
In Vivo Recording of the Adult Zebrafish Electrocardiogramp. 65
Introductionp. 65
Optimization of Zebrafish Electrocardiogram Recordingp. 66
Basic Intervasp. 68
Drug Effectsp. 69
Conclusionsp. 71
Referencesp. 72
Hematopoietic and Vascular System Toxicityp. 73
Introductionp. 73
Hematopoiesis and Vascular Development in the Zebrafishp. 73
Morphological and Functional Assays to Assess Toxicityp. 77
Summaryp. 85
Acknowledgementp. 85
Referencesp. 85
Hepatotoxicity Testing in Larval Zebrafishp. 89
Introduction: The Larval Zebrafish Modelp. 89
Liver Developmentp. 89
Hepatic Gene Knockdown and Mutationp. 91
Hepatotoxicity Testing in Drug Discoveryp. 92
Phenotypic-Based Larval Zebrafish Hepatotoxicity Screensp. 93
Secondary and Mechanistic Liver Assaysp. 96
Conclusionsp. 99
Referencesp. 99
Whole Zebrafish Cytochrome P450 Assay for Assessing Drug Metabolism and Safetyp. 103
Introductionp. 103
Background and Significancep. 104
Materials and Methodsp. 105
Resultsp. 107
Conclusionsp. 113
Acknowledgementp. 113
Referencesp. 113
Methods for Assessing Neurotoxicity in Zebrafishp. 117
Introductionp. 117
Limitations of Current Neurotoxicity Testingp. 118
Assessing Neurotoxicity in Zebrafishp. 118
Summaryp. 130
Acknowledgementp. 131
Referencesp. 131
Zebrafish: A Predictive Model for Assessing Cancer Drug-Induced Organ Toxicityp. 155
Introductionp. 135
Materials and Methodsp. 136
Resultsp. 139
Conclusionsp. 149
Referencesp. 149
Locomotion and Behavioral Toxicity in Laraval Zebrafish: Background, Methods, and Datap. 151
Introductionp. 151
Backgroundp. 152
Locomotionp. 153
Zebrafish Modelsp. 154
Analyzing Larval Locomotionp. 155
Chemical Effects on Larval Locomotionp. 158
Conclusionsp. 161
Acknowledgementp. 162
Referencesp. 162
Zebrafish: A Predictive Model for Assessing Seizure Liabilityp. 165
Introductionp. 165
Materials and Methodsp. 167
Resultsp. 171
Conclusionsp. 174
Referencesp. 175
Zebrafish: A New In Vivo Model for Identifying P-Glycoprotein Efflux Modulatorsp. 177
Introductionp. 177
Materials and Methodsp. 179
Resultsp. 182
Conclusionsp. 188
Acknowledgmentsp. 188
Referencesp. 189
Assessment of Effects on Visual Function in Larval Zebrafishp. 191
Introductionp. 191
Development of Visual System in Zebrafishp. 192
Methods for Assessing Visual Function in Larval Zebrafishp. 194
Conclusionsp. 202
Referencesp. 202
Development of a Hypoxia-Induced Zebrafish Choroidal Neovascularization Modelp. 205
Introductionp. 205
Materials and Methodsp. 207
Resultsp. 210
Discussionp. 215
Acknowledgmentsp. 217
Referencesp. 217
Zebrafish Xenotransplant Cancer Model for Drug Screeningp. 219
Introductionp. 219
Background and Significancep. 219
Materials and Methodsp. 221
Results
Conclusionsp. 230
Referencesp. 231
Zebrafish Assays for Identifying Potential Muscular Dystrophy Drug Candidatesp. 233
Introductionp. 233
Materials and Methodsp. 238
Resultsp. 242
Discussionp. 251
Acknowledgmentp. 252
Referencesp. 252
Cytoprotective Activities of Water-Soluble Fullerenes in Zebrafish Modelsp. 257
Introductionp. 257
Materials and Methodsp. 261
Resultsp. 265
Discussionp. 277
Conclusionsp. 278
Acknowledgmentsp. 278
Referencesp. 279
Fishing to Design Inherently Safer Nanoparticlesp. 283
Introductionp. 283
Application of Embryonic Zebrafishp. 284
Tier 1: Rapid Toxicity Screeningp. 286
Tier 2: Cellular Toxicity and Distributionp. 288
Tier 3: Molecular Expressionp. 289
Embryonic Zebrafish Data to Design "Safer" Nanoparticlesp. 291
Conclusionsp. 292
Referencesp. 292
Radiation-Induced Toxicity and Radiation Response Modifiers in Zebrafishp. 295
Introductionp. 295
Materials and Methodsp. 296
Validation of Zebrafish Embryos as a Model System for Radiation Protectors/Sensitizersp. 298
Gross Morphological Alterations Associated with Radiation Exposurep. 299
Radiation-Associated Apoptosis Incidencep. 299
Radiation-Associated Gastrointestinal Toxicityp. 300
Radiation-Associated Nephrotoxicityp. 301
Ototoxicity in Irradiated Zebrafishp. 301
Radiation Protectors in Zebrafishp. 302
Summaryp. 303
Referencesp. 304
Caudal Fin Regeneration in Zebrafishp. 307
Introductionp. 307
Signaling and Epimorphic Regenerationp. 308
Caudal Fin Architecturep. 308
Stages of Epimorphic Regenerationp. 309
Methodologyp. 311
Strategies Used to Manipulate Gene Function During Fin Regenerationp. 312
The Largal Fin Regeneration Modelp. 316
Summaryp. 317
Acknowledgementp. 317
Referencesp. 317
Indexp. 321
Table of Contents provided by Ingram. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program